![](/img/cover-not-exists.png)
6048 A comparison of efficacy of first-line chemotherapy regimens for metastatic colorectal cancer (mCRC): FOLFIRI+ bevacizumab vs. XELIRI+ bevacizumab
Ocvirk, J., Rebersek, M., Boc, M.Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71143-7
Date:
September, 2009
File:
PDF, 47 KB
english, 2009